Home remedies for postnasal drip include foods and diet, using a neti pot, trying aromatherapy, and staying hydrated. Causes of postnatal drip can include infection and allergies. Postnasal drip can ...

Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...

Here’s what you need to know about nasal spray dependency, the symptoms to watch out for, and how to manage withdrawal. When congestion sets in, the cause is typically inflammation in the nasal ...

LANSING, Mich. (WLNS) — If you purchased a generic prescription drug manufactured by Heritage Pharmaceuticals or Apotex between 2010 and 2018, you may be eligible for compensation. 50 states and ...

Connecticut Attorney General William Tong announced two cooperation agreements and settlements with Heritage Pharmaceuticals and Apotex Corp., totaling $49.1 million, due to each companies ...

The cofounder of B Lab, the global nonprofit that came up with the B Corp certification for accountable, sustainable, and transparent companies, believes that OpenAI should sign up to its system ...

DDVAP: Desmopressin; DHE: Dihydroergotamine; L-DOPS: Droxidopa; Non-RCT: Nonrandomized, controlled trial data, for example, open-label studies or observational ...

Attorney General Phil Weiser announced the $10 million settlement with Heritage Pharmaceuticals and $39.1 million settlement with Apotex on Thursday. Colorado joined three multistate lawsuits ...

Intel Corp faces significant restructuring charges and asset impairments amidst a challenging market. The company's shift towards an internal foundry model and AI strategy reflects a strategic ...

Delaware was one of 50 states and territories to reach cooperation agreements and settlements with Heritage Pharmaceuticals and Apotex for their reported efforts to manipulate prices, reduce ...

Gener­ic drug man­u­fac­tur­ers Her­itage Phar­ma­ceu­ti­cals and Apo­tex have agreed to pay $49.1 mil­lion to set­tle al­le­ga­tions from near­ly all US states that the com­pa­ ...

(Bloomberg) -- Canadian generic drug manufacturer Apotex Inc. is making plans for a potential initial public offering next year, according to people familiar with the matter. RBC Capital Markets, ...